Tirzepatide also mimics another hormone, glucose-dependent insulinotropic polypeptide (GIP), making it a dual GLP-1/GIP receptor agonist
significant hypoglycaemia is uncommon with tirzepatide monotherapy but more likely when combined with insulin or sulphonylureas
Both compounds influence hydration status, renal function markers, and muscle metabolismmaking baseline kidney function evaluation essential before combining them
Metformin and GLP-1 receptor agonists are two separate medication classes that address metabolic health in fundamentally different ways
Sugar- and Artificially Sweetened Beverages Consumption Linked to Type 2 Diabetes, Cardiovascular Diseases, and All-Cause Mortality: A Systematic Review and Dose-Response Meta-Analysis of Prospective Cohort Studies
In addition, these medications may increase the risk of gallbladder disease, acute kidney injury, and allergic reactions